Thursday, September 24, 2020
wellness India Expo
Home Tags Dr Renu Swarup

Tag: Dr Renu Swarup

C-CAMP flags off 4th edition of National Bio Entrepreneurship Competition

Held by the Centre for Cellular and Molecular Platforms every year to attract, identify and nurture pathbreaking deep science-driven business ideas, the competition is a nationwide search for ideas with significant potential for societal impact in the life sciences domain................

Pune’s Venture Center opens Center for Biopharma Analysis to support National...

Center for Biopharma Analysis at Venture Center, hosted by CSIR-National Chemical Laboratory in Pune will provide high-quality analytical services for biopharmaceutical developers and manufacturers.................

COVID-19: Supported by DBT, Serum Institute’s rBCG vaccine efficacy trial enrolls...

Serum Institute of India has been supported under the Department of Biotechnology’s National Biopharma Mission for conduct of a multisite randomized double-blinded placebo-controlled phase III clinical trial of a recombinant BCG vaccine candidate, VPM1002.............................

Mylab scales up its COVID-19 test kit production with DBT support

Pune-based Mylab Discovery Solutions has scaled up its production and development of COVID-19 path detect testing kit with the help of strategic funding under National Biopharma Mission of Department of Biotechnology and Biotechnology Industry Research Assistance Council.......................

Govt releases guidelines for evaluation of nano-based Agri-input & food products

These ‘Guidelines’ would help policy makers and regulators to frame effective provisions for future novel nano-based products in the agri-input and food sectors of India.....................

India’s first mobile COVID-19 diagnostic unit, I-Lab created in record 8...

This mobile testing facility that has biosafety facility and is capable of performing RT-PCR as well as ELISA tests, will be deployed through the DBT testing hubs to remote regions of the country.....................

COVID-19: DBT’s NBRIC emerges as key convergence platform to fuel Made-in-India...

Within a month of its inception, the National Biomedical Resources Indigenization Consortium constituted by the Department of Biotechnology, has seen active engagement from several major stakeholders of Indian biomedical resources innovation community

Sun Pharma initiates Phase II clinical trial of first phytopharma drug...

Clinical trial of the drug that has shown anti-SARS-CoV-2 effects in in-vitro studies conducted in collaboration with ICGEB will be conducted across 12 centers in India in 210 patients; results expected by October 2020.............................

UNHIE, BIRAC & Social Alpha announce ‘India Accelerator Platform for Healthcare...

Initiative to fast track adoption, ease access and market entry to enable universal healthcare. Platform will lead to successful adoption of at least 100 Indian innovations in 5 years; leading to creation of new market opportunities worth $500 million for India’s MedTech start-ups....................

Mega biotech show, Global Bio-India concludes in New Delhi

The three-day first of its kind mega event featured an investors meeting, an exhibition, webinars, hackathons, and business to business meetings and showcase key biotechnological innovations, products, services, and technologies